| Autor: |
Madan, Shikha, Duhan, Nirmala, Anand, Smriti, Sen, Jyotsna |
| Předmět: |
|
| Zdroj: |
Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research); 2024, Vol. 15 Issue 1, p2289-2292, 4p |
| Abstrakt: |
Introduction: Uterine myomas are very common benign tumours of the uterus. The patients may not be willing or may not be fit for surgical procedures. Medical management is done in a few cases. The perimenopausal age group is high risk for cardiovascular accidents. Hence, the side effects of the medical management should be considered. Material and Methods: The study was done in 30 perimenopausal patients with uterine myomas. 2.5 mg of Letrozole (Aromatase Inhibitor) was given for 3 months. The hormonal profile and lipid profile was done to know about the risk of increasing cardiovascular accidents in these patients. Results: Letrozole when used for 3 months did not change the hormonal profile and lipid profile of the patients. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
